Establishment of Peripheral Blood-Derived Induced Pluripotent Stem Cells (iPS Cells) in Patients with Gastric Polyposis

Establishment of Peripheral Blood-Derived Induced Pluripotent Stem Cells (iPS Cells) in Patients with Gastric Polyposis - Establishment of Peripheral Blood-Derived Induced Pluripotent Stem Cells (iPS Cells) in Patients with Gastric Polyposis

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000052317

Enrollment

Registered

2023-09-27

Start date

2023-09-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric polyposis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with and without gastric polyposis

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
We establish induced pluripotent stem cells (iPS cells) from peripheral blood of both gastric polyposis patients and patients without gastric polyposis (control group). Subsequently, we generate gastric organoids from iPS cells established from each patient and analyze the morphology of these organoids.	—

Countries

Japan

Contacts

Public ContactMasaya Iwamuro

Okayama University Hospital Department of Gastroenterology

iwamuromasaya@yahoo.co.jp0862357218

Outcome results